| Ident. | Authors (with country if any) | Title |
|---|
| 000026 (2013) |
Christopher G. Goetz [États-Unis] ; Glenn T. Stebbins [États-Unis] ; Kathryn A. Chung [États-Unis] ; Robert A. Hauser [États-Unis] ; Janis M. Miyasaki [Canada] ; Anthony P. Nicholas [États-Unis] ; Werner Poewe [Autriche] ; Klaus Seppi [Autriche] ; Olivier Rascol [France] ; Mark A. Stacy [États-Unis] ; John G. Nutt [États-Unis] ; Caroline M. Tanner [États-Unis] ; Alison Urkowitz [États-Unis] ; Jean A. Jaglin [États-Unis] ; Song Ge [États-Unis] | Which dyskinesia scale best detects treatment response? |
| 000034 (2013) |
Lena C. Quilty [Canada] ; Jennifer J. Robinson [Canada] ; Jean-Pierre Rolland [France] ; Filip De Fruyt [Belgique] ; Frédéric Rouillon [France] ; R. Michael Bagby [Canada] | The structure of the Montgomery–Åsberg depression rating scale over the course of treatment for depression |
| 000060 (2013) |
Jan-Marie Kozicky [Canada] ; Tae Hyon Ha [Canada, Corée du Sud] ; Ivan J. Torres [Canada] ; David J. Bond [Canada] ; William G. Honer [Canada] ; Raymond W. Lam [Canada] ; Lakshmi N. Yatham [Canada] | Relationship between frontostriatal morphology and executive function deficits in bipolar I disorder following a first manic episode: data from the Systematic Treatment Optimization Program for Early Mania (STOP‐EM) |
| 000086 (2013) |
Seung U. Kim [Corée du Sud, Canada] ; Hong J. Lee [Corée du Sud, Canada] ; Yun B. Kim [Corée du Sud] | Neural stem cell‐based treatment for neurodegenerative diseases |
| 000087 (2013) |
Moonhee Lee [Canada] ; Edith Mcgeer [Canada] ; Ravinder Kodela [États-Unis] ; Khosrow Kashfi [États-Unis] ; Patrick L. Mcgeer [Canada] | NOSH‐aspirin (NBS‐1120), a novel nitric oxide and hydrogen sulfide releasing hybrid, attenuates neuroinflammation induced by microglial and astrocytic activation: A new candidate for treatment of neurodegenerative disorders |
| 000125 (2013) |
K. A. Papp [Canada] ; R. G. Langley [Canada] ; B. Sigurgeirsson [Islande] ; M. Abe [Japon] ; D. R. Baker [États-Unis] ; P. Konno [Estonie] ; S. Haemmerle [Suisse] ; H. J. Thurston [Suisse] ; C. Papavassilis [Suisse] ; H. B. Richards [Suisse] | Efficacy and safety of secukinumab in the treatment of moderate‐to‐severe plaque psoriasis: a randomized, double‐blind, placebo‐controlled phase II dose‐ranging study |
| 000149 (2013) |
D. William Molloy [Irlande (pays)] ; T. I. Standish [Canada] ; Q. Zhou [Canada] ; G. Guyatt [Canada] | A multicenter, blinded, randomized, factorial controlled trial of doxycycline and rifampin for treatment of Alzheimer's disease: the DARAD trial |
| 000396 (2011) |
Connie Marras [Canada] ; Michael P. Mcdermott [États-Unis] ; Ken Marek [États-Unis] ; Paula Rochon [Canada] ; Gary Naglie [Canada] ; Caroline M. Tanner [États-Unis] ; Alice Rudolph [États-Unis] ; Ira Shoulson [États-Unis] ; Anthony E. Lang [Canada] | Predictors of time to requiring dopaminergic treatment in 2 Parkinson's disease cohorts |
| 000478 (2011) |
Daniela Berg [Allemagne] ; Jana Godau [Allemagne] ; Claudia Trenkwalder [Allemagne] ; Karla Eggert [Allemagne] ; Iiona Csoti [Allemagne] ; Alexander Storch [Allemagne] ; Heiko Huber [Allemagne] ; Monica Morelli-Canelo [Allemagne] ; Maria Stamelou [Allemagne] ; Vincent Ries [Allemagne] ; Martin Wolz [Allemagne] ; Christine Schneider [Allemagne] ; Thérèse Di Paolo [Canada] ; Fabrizio Gasparini [Suisse] ; Sam Hariry [Suisse] ; Marc Vandemeulebroecke [Suisse] ; Walid Abi-Saab [Suisse] ; Katy Cooke [Royaume-Uni] ; Donald Johns [Suisse] ; Baltazar Gomez-Mancilla [Suisse] | AFQ056 treatment of levodopa‐induced dyskinesias: Results of 2 randomized controlled trials |
| 000544 (2010) |
Tiago Mestre [Portugal] ; Anthony E. Lang [Canada] | The grasp reflex: A symptom in need of treatment |
| 000553 (2010) |
William Jarnagin [États-Unis] ; William C. Chapman ; Steven Curley ; Michael D'Angelica ; Charles Rosen ; Elijah Dixon ; David Nagorney [États-Unis] | Surgical treatment of hepatocellular carcinoma: expert consensus statement |
| 000571 (2010) |
Robert Chen [Canada] | Repetitive transcranial magnetic stimulation as treatment for depression in Parkinson's disease |
| 000675 (2009) |
Connie Marras [Canada] ; Anthony E. Lang [Canada] ; Shirley W. Eberly [États-Unis] ; David Oakes [États-Unis] ; Stanley Fahn [États-Unis] ; Steven R. Schwid [États-Unis] ; Christopher Hyson [Canada] ; Ira Shoulson [États-Unis] | A comparison of treatment thresholds in two large Parkinson's disease clinical trial cohorts |
| 000726 (2009) |
A. C. Ludolph [Allemagne] ; J. Kassubek [Allemagne] ; B. G. Landwehrmeyer [Allemagne] ; E. Mandelkow [Allemagne] ; E. Mandelkow [Allemagne] ; D. J. Burn [Royaume-Uni] ; D. Caparros-Lefebvre [France] ; K. A. Frey [États-Unis] ; J. G. De Yebenes [Espagne] ; T. Gasser [Allemagne] ; P. Heutink [Pays-Bas] ; G. Höglinger [Allemagne] ; Z. Jamrozik [Pologne] ; K. A. Jellinger [Autriche] ; A. Kazantsev [États-Unis] ; H. Kretzschmar [Allemagne] ; A. E. Lang [Canada] ; I. Litvan [États-Unis] ; J. J. Lucas [Espagne] ; P. L. Mcgeer [Canada] ; S. Melquist [États-Unis] ; W. Oertel [Allemagne] ; M. Otto [Allemagne] ; D. Paviour [Royaume-Uni] ; T. Reum [Allemagne] ; A. Saint-Raymond [Royaume-Uni] ; J. C. Steele ; M. Tolnay [Suisse] ; H. Tumani [Allemagne] ; J. C. Van Swieten [Pays-Bas] ; M. T. Vanier [France] ; J. Vonsattel [États-Unis] ; S. Wagner [Allemagne] ; Z. K. Wszolek [États-Unis] | Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options |
| 000806 (2009) |
Barbara Collins [Canada] ; Joyce Mackenzie [Canada] ; Angela Stewart [Canada] ; Catherine Bielajew [Canada] ; Shailendra Verma [Canada] | Cognitive effects of chemotherapy in post‐menopausal breast cancer patients 1 year after treatment |
| 000812 (2009) |
Aw Zuardi [Brésil] ; Jas Crippa [Brésil] ; Jec Hallak [Brésil] ; Jp Pinto [Brésil] ; Mhn Chagas [Brésil] ; Ggr Rodrigues [Brésil] ; Sm Dursun [Canada] ; V. Tumas [Brésil] | Cannabidiol for the treatment of psychosis in Parkinson’s disease |
| 000926 (2008) |
Behnam A. Baghbaderani [Canada] ; Karim Mukhida [Canada] ; Arindom Sen [Canada] ; Murray Hong [Canada] ; Ivar Mendez [Canada] ; Leo A. Behie [Canada] | Expansion of Human Neural Precursor Cells in Large‐Scale Bioreactors for the Treatment of Neurodegenerative Disorders |
| 000956 (2008) |
Bernard Le Foll [Niger] ; Benoit Forget ; Henri-Jean Aubin [France] ; Steven R. Goldberg [États-Unis] | Blocking cannabinoid CB1 receptors for the treatment of nicotine dependence: insights from pre‐clinical and clinical studies |
| 000958 (2008) |
Richard L. Page [États-Unis] ; Edward L. C. Pritchett [États-Unis] ; Stuart Connolly [Canada] ; William E. Wilkinson [États-Unis] | Azimilide for the Treatment of Atrial Fibrillation, Atrial Flutter, and Paroxysmal Supraventricular Tachycardia: Results of a Randomized Trial and Insights on the Concordance of Symptoms and Recurrent Arrhythmias |
| 000974 (2007) |
Kerrie L. Schoffer [Australie, Canada] ; Robert D. Henderson [Australie] ; Karen O'Maley [Australie] ; John D. O'Sullivan [Australie] | Nonpharmacological treatment, fludrocortisone, and domperidone for orthostatic hypotension in Parkinson's disease |
| 000A33 (2007) |
Rohita Sharma [Canada] ; Catherine R. Mcmillan [Canada] ; Lennard P. Niles [Canada] | Neural stem cell transplantation and melatonin treatment in a 6‐hydroxydopamine model of Parkinson’s disease |
